Memorial Sloan-Kettering Cancer Center Sleepy Hollow: Clinical Trials at Sleepy Hollow

Browse our continually updated listing of clinical trials available to patients at Memorial Sloan-Kettering Cancer Center Sleepy Hollow below. You can also explore our complete listing of clinical trials available at Memorial Sloan-Kettering.

Showing 21 - 40 of 75 trials
Titlesort icon Investigator Disease(s)
A Phase III Study of ProstAtakTM as an Adjuvant to Up-front Radiation Therapy for Localized Prostate Cancer
[Protocol 11-172] 		Zelefsky, Michael
  • Prostate Cancer
    • Localized Disease
A Phase III Study of Postoperative Radiation Therapy with and without Cetuximab for Locally Advanced Resected Head and Neck Cancer
[Protocol 10-081] 		Lee, Nancy
  • Head & Neck Cancer
A Phase III Study of Paclitaxel plus Carboplatin Versus Ifosfamide plus Paclitaxel in Chemotherapy-Naive Patients with Newly Diagnosed Persistent or Recurrent Carcinosarcoma of the Uterus
[Protocol 10-007] 		Hensley, Martee
  • Endometrial and other Uterine Cancers
    • Uterine Cancer
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase III Study of Lenalidomide, Bortezomib, and Dexamethasone Combination Treatment with or without Peripheral Stem Cell Transplantation in the Initial Management of Multiple Myeloma
[Protocol 12-018] 		Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase III Study of Hormone Therapy with and without Chemotherapy in Patients with HER2-Negative Breast Cancer and 1-3 Positive Lymph Nodes and a Recurrence Score of 25 or Less
[Protocol 12-118] 		Lake, Diana
  • Breast Cancer
A Phase III Study of Gemcitabine, Docetaxel, and Doxorubicin versus Observation in Women with High-Grade Uterine Leiomyosarcoma
[Protocol 12-177] 		Hensley, Martee
  • Endometrial and other Uterine Cancers
    • Leiomyosarcoma
    • Uterine Cancer
  • Leiomyosarcoma
  • Sarcomas
    • Leiomyosarcoma
    • Soft Tissue Sarcoma
A Phase III Study of Gemcitabine and Cisplatin with and without Bevacizumab in Patients with Advanced Transitional Cell Carcinoma
[Protocol 12-119] 		Rosenberg, Jonathan
  • Bladder Cancer
  • Kidney Cancer
A Phase III Study of Etoposide/Platinum with and without Ipilimumab in Patients with Newly Diagnosed Advanced Small Cell Lung Cancer
[Protocol 12-202] 		Pietanza, M. Catherine
  • Lung Cancer
  • Lung Cancer, Small Cell
A Phase III Study of Chemotherapy and Trastuzumab with or without Pertuzumab in Patients with Operable HER2-Positive Breast Cancer
[Protocol 12-115] 		Dang, Chau
  • Breast Cancer
A Phase III Study of BKM120 with Fulvestrant in Postmenopausal Women with Locally Advanced or Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer
[Protocol 12-290] 		Dickler, Maura
  • Breast Cancer
A Phase III Study of Accelerated Whole Breast Radiation Therapy with a Boost versus Standard Whole Breast Radiation with a Boost in Women with Early-Stage Breast Cancer (RTOG 1005)
[Protocol 12-158] 		Parhar, Preeti
  • Breast Cancer
A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
[Protocol 11-003] 		Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgery in Patients with Locally Advanced Thymoma
[Protocol 09-038] 		Huang, James
  • Thymoma
A Phase II Trial of Bevacizumab, Cetuximab, Cisplatin, and Intensity-Modulated Radiation Therapy for Patients with Stage III/IV Head and Neck Squamous Cell Carcinoma
[Protocol 09-083] 		Fury, Matthew
  • Head & Neck Cancer
A Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma
[Protocol 08-053] 		Krug, Lee
  • Mesothelioma
A Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
[Protocol 12-131] 		Hyman, David
  • Hematology
    • Hematologic Disorders
    • Multiple Myeloma
A Phase II Study of Temozolomide Alone or with ABT-888 (Veliparib) in Patients with Relapsed or Refractory Small Cell Lung Cancer
[Protocol 12-021] 		Pietanza, M. Catherine
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase II Study of Siltuximab in Patients with High-Risk Smoldering Multiple Myeloma
[Protocol 12-068] 		Lesokhin, Alexander
  • Hematology
    • Multiple Myeloma
A Phase II Study of Secondary Cytoreduction with and without HIPEC plus Postoperative Chemotherapy for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-275] 		Chi, Dennis
  • Ovarian Cancer
A Phase II Study of Repeat Breast-Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation for Local Recurrence of Breast Cancer
[Protocol 10-152] 		McCormick, Beryl
  • Breast Cancer